Clinical Trials Browser

Phase NA × Unknown × HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy × Clear all

NCT05560308 2022-10-03

Phase II Clinical Study of T-DM1 and Pyrotinib Maleate in Patients With HER2-positive Metastatic Breast Cancer Who Had Progressed on TKI Therapy

Phase NA Unknown

HER2+ Advanced Breast Cancer Patients Progressing on TKI Therapy